We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications

Article   Jul 29, 2020

 
Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications
 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

Vital Lessons for the Diagnostics Industry From COVID-19

Article

While coronavirus has brought together the industry around a common goal, it has also shone a light on the challenges in developing and bringing diagnostic tests to market in exceptional circumstances. It is important that we learn from these challenges so that our industry is better prepared.

READ MORE

Can We Fool SARS-CoV-2 With a Decoy Receptor for Cell Entry?

Article

There is a current lack of effective therapeutics with which to fight SARS-CoV-2. Could creating a "trick" version of the ACE2 receptor, the virus' entry point into cells, be the answer? We speak with Erik Procko to learn more about his research in this space.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE